Jim Cornall

biotech

First gene therapy delivers missing gene to infant’s brain

biotech

New therapy may reverse autism-related brain deficits

biotech

Biomarker-guided immunosuppression following kidney transplantation successfully tested

biotech

Data show cardiometabolic benefits of Type 2 diabetes treatment

biotech

Orphan Drug Designation for potential best-in-class ADC for sarcoma

biotech

FDA Breakthrough Therapy Designation for spinal muscular atrophy treatment

biotech

Servier acquiring Edgewise Therapeutics’ muscular dystrophy business

biotech

Antibody fragment prevents haemorrhages associated with new Alzheimer’s treatments